A linear polyethylenimine (LPEI) drug conjugate with reversible charge to overcome multidrug resistance in cancer cells

Polymer

Volumn 76, Issue , 2015, Pages 150-158

  Zhou, Zhuxian ^a,b   Murdoch, William J ^c   Shen, Youqing ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY OF WYOMING   (United States)

^c UNIVERSITY OF WYOMING   (United States)

Author keywords

Camptothecin; Cancer drug delivery; Linear polyethyleneimine (LPEI) drug conjugate; Multidrug resistance; Nuclear delivery; Reversible charge

Indexed keywords

BODY FLUIDS; CELLS; CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; COVALENT BONDS; CYTOLOGY; DISEASES; DYES; SULFUR COMPOUNDS;

CAMPTOTHECIN (CPT); CANCER DRUG DELIVERIES; DRUG-CONJUGATES; MULTIDRUG RESISTANCE; NUCLEAR DELIVERY; REVERSIBLE CHARGE;

TARGETED DRUG DELIVERY;

EID: 84941113917     PISSN: 00323861     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.polymer.2015.08.061     Document Type: Article

References (48)

1. R. Duncan, and M.J. Vicent Polymer therapeutics-prospects for 21st century: the end of the beginning Adv. Drug Deliv. Rev. 65 2013 60 70
2. J. Kopecek Polymer-drug conjugates: origins, progress to date and future directions Adv. Drug Deliv. Rev. 65 2013 49 59
3. N. Larson, and H. Ghandehari Polymeric conjugates for drug delivery Chem. Mater. 24 2012 840 853
4. V. Percec, D.A. Wilson, P. Leowanawat, C.J. Wilson, A.D. Hughes, M.S. Kaucher, and et al. Self-assembly of Janus dendrimers into uniform dendrimersomes and other complex architectures Science 328 2010 1009 1014
5. Z. Zhou, X. Ma, C.J. Murphy, E. Jin, Q. Sun, Y. Shen, and et al. Molecularly precise dendrimer-drug conjugates with tunable drug release for cancer therapy Angew. Chem. Int. Ed. 53 2014 10949 10955
6. Q. Sun, X. Sun, X. Ma, Z. Zhou, E. Jin, B. Zhang, and et al. Integration of nanoassembly functions for an effective delivery cascade for cancer drugs Adv. Mater. 26 2014 7615 7621
7. Z. Zhou, and Z.R. Lu Dendritic nanoglobules with polyhedral oligomeric silsesquioxane core and their biomedical applications Nanomedicine-UK 9 2014 2387 2401
8. H. Yoon, E.J. Dell, J.L. Freyer, L.M. Campos, and W.D. Jang Polymeric supramolecular assemblies based on multivalent ionic interactions for biomedical applications Polymer 55 2014 453 464
9. T.M. Allen, and P.R. Cullis Liposomal drug delivery systems: from concept to clinical applications Adv. Drug Deliv. Rev. 65 2013 36 48
10. J.W. Nichols, and Y.H. Bae Odyssey of a cancer nanoparticle: from injection site to site of action Nano Today 7 2012 606 618
11. Z. Zhou, X. Ma, E. Jin, J. Tang, M. Sui, Y. Shen, and et al. Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery Biomaterials 34 2013 5722 5735
12. L. Jiang, Z.M. Gao, L. Ye, A.Y. Zhang, and Z.G. Feng A tumor-targeting nano doxorubicin delivery system built from amphiphilic polyrotaxane-based block copolymers Polymer 54 2013 5188 5198
13. Y. Wang, K. Zhou, G. Huang, C. Hensley, X. Huang, X. Ma, and et al. A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals Nat. Mater. 13 2014 204 212
14. Y. Shen, Z. Zhou, M. Sui, J. Tang, P. Xu, E.A. Van Kirk, and et al. Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery Nanomedicine-UK 5 2010 1205 1217
15. J.Y. Fang, P.W. Hsieh, and C.F. Hung Current prodrug design for drug discovery Curr. Pharm. Des. 15 2009 2236 2250
16. F. Alexis, E. Pridgen, L.K. Molnar, and O.C. Farokhzad Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol. Pharm. 5 2008 505 515
17. H. Maeda, H. Nakamura, and J. Fang The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo Adv. Drug Deliv. Rev. 65 2013 71 79
18. Z. Zhou, Y. Shen, J. Tang, E. Jin, X. Ma, Q. Sun, and et al. Linear polyethyleneimine-based charge-reversal nanoparticles for nuclear-targeted drug delivery J. Mater. Chem. 21 2011 19114 19123
19. Y.J. Lu, and P.S. Low Folate-mediated delivery of macromolecular anticancer therapeutic agents Adv. Drug Deliv. Rev. 54 2002 675 693
20. Y.F. Wang, P.F. Liu, L.H. Qiu, Y. Sun, M.J. Zhu, L.Y. Gu, and et al. Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice Biomaterials 34 2013 4068 4077
21. T. Iwamoto Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs Biol. Pharm. Bull. 36 2013 715 718
22. A.A.M. van der Veldt, M. Lubberink, R.H.J. Mathijssen, W.J. Loos, G.J.M. Herder, H.N. Greuter, and et al. Toward prediction of efficacy of chemotherapy: a proof of concept study in lung cancer patients using [C-11]docetaxel and positron emission tomography Clin. Cancer Res. 19 2013 4163 4173
23. L.H. Hurley DNA and its associated processes as targets for cancer therapy Nat. Rev. Cancer 2 2002 188 200
24. T. Yamagishi, S. Sahni, D.M. Sharp, A. Arvind, P.J. Jansson, and D.R. Richardson P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration J. Biol. Chem. 288 2013 31761 31771
25. M. Duvvuri, and J.P. Krise Intracellular drug sequestration events associated with the emergence of multidrug resistance: a mechanistic review Front. Biosci. 10 2005 1499 1509
26. N.K.H. Slater, R. Chen, S. Khormaee, and M.E. Eccleston The role of hydrophobic amino acid grafts in the enhancement of membrane-disruptive activity of pH-responsive pseudo-peptides Biomaterials 30 2009 1954 1961
27. E. Koren, and V.P. Torchilin Cell-penetrating peptides: breaking through to the other side Trends Mol. Med. 18 2012 385 393
28. E. Jin, B. Zhang, X. Sun, Z. Zhou, X. Ma, Q. Sun, and et al. Acid-active cell-penetrating peptides for in vivo tumor-targeted drug delivery J. Am. Chem. Soc. 135 2013 933 940
29. O. Boussif, F. Lezoualc'h, M.A. Zanta, M.D. Mergny, D. Scherman, B. Demeneix, and et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl. Acad. Sci. U. S. A. 92 1995 7297 7301
30. C. Rudolph, M. Elfinger, C. Pfeifer, S. Uezguen, M.M. Golas, B. Sander, and et al. Self-assembly of ternary insulin-polyethylenimine (PEI)-DNA nanoparticles for enhanced gene delivery and expression in alveolar epithelial cells Biomacromolecules 10 2009 2912 2920
31. J.P. Behr The proton sponge: a trick to enter cells the viruses did not exploit Chimia 51 1997 34 36
32. E. Moreau, M. Domurado, P. Chapon, M. Vert, and D. Domurado Biocompatibility of polycations: in vitro agglutination and lysis of red blood cells and in vivo toxicity J. Drug Target. 10 2002 161 173
33. Q. Sun, M. Radosz, and Y. Shen Challenges in design of translational nanocarriers J. Control Release 164 2012 156 169
34. H. Yim, S.J. Park, Y.H. Bae, and K. Na Biodegradable cationic nanoparticles loaded with an anticancer drug for deep penetration of heterogeneous tumours Biomaterials 34 2013 7674 7682
35. P. Xu, E.A. Van Kirk, Y. Zhan, W.J. Murdoch, M. Radosz, and Y. Shen Targeted charge-reversal nanoparticles for nuclear drug delivery Angew. Chem. Int. Ed. 46 2007 4999 5002
36. K. Kataoka, Y. Lee, T. Ishii, H. Cabral, H.J. Kim, J.H. Seo, and et al. Charge-conversional polyionic complex micelles-efficient nanocarriers for protein delivery into cytoplasm Angew. Chem. Int. Ed. 48 2009 5309 5312
37. J.Z. Du, T.M. Sun, W.J. Song, J. Wu, and J. Wang A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery Angew. Chem. Int. Ed. 49 2010 3621 3626
38. Z. Zhou, Y. Shen, J. Tang, M. Fan, E.A. Van Kirk, W.J. Murdoch, and et al. Charge-reversal drug conjugate for targeted cancer cell nuclear drug delivery Adv. Funct. Mater. 19 2009 3580 3589
39. A. Akinc, and R. Langer Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking Biotechnol. Bioeng. 78 2002 503 508
40. W. Liang, and J.K.W. Lam Endosomal escape pathways for non-viral nucleic acid delivery systems B. Ceresa, Molecular Regulation of Endocytosis 2012 429 456 Chapter 17
41. R.G. Schoenmakers, P. van de Wetering, D.L. Elbert, and J.A. Hubbell The effect of the linker on the hydrolysis rate of drug-linked ester bonds J. Control Release 95 2004 291 300
42. H. Xie, O. Braha, L.Q. Gu, S. Cheley, and H. Bayley Single-molecule observation of the catalytic subunit of cAMP-dependent protein kinase binding to an inhibitor peptide Chem. Biol. 12 2005 109 120
43. M.E.H. El-Sayed, A.S. Hoffman, and P.S. Stayton Rational design of composition and activity correlations for pH-sensitive and glutathione-reactive polymer therapeutics J. Control Release 101 2005 47 58
44. K. Newell, A. Franchi, J. Pouyssegur, and I. Tannock Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity Proc. Natl. Acad. Sci. U. S. A. 90 1993 1127 1131
45. I.F. Tannock, and D. Rotin Acid pH in tumors and its potential for therapeutic exploitation Cancer Res. 49 1989 4373 4384
46. D.P. Jones, J.L. Carlson, P.S. Samiec, P. Sternberg, V.C. Mody, R.L. Reed, and et al. Glutathione measurement in human plasma evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC Clin. Chim. Acta 275 1998 175 184
47. S. Mura, J. Nicolas, and P. Couvreur Stimuli-responsive nanocarriers for drug delivery Nat. Mater. 12 2013 991 1003
48. F.L. Feng, R.R. Li, Q.Y. Zhang, Y.S. Wang, X.Y. Yang, H.Q. Duan, and et al. Preparation of reduction-triggered degradable microcapsules for intracellular delivery of anti-cancer drug and gene Polymer 55 2014 110 118